A commonly used diabetes medication could improve long-term recovery for cancer patients, according to research from the University of East Anglia....
Vous n'êtes pas connecté
SGLT2 inhibitors, a diabetes medication, may protect the heart and reduce hospitalizations for cancer patients, particularly those treated with chemotherapy.
A commonly used diabetes medication could improve long-term recovery for cancer patients, according to research from the University of East Anglia....
A new study suggests that medications commonly used for diabetes, including the popular drug Ozempic, may help reduce the risk of certain...
Patients with castration-resistant metastatic prostate cancer with or without HRR gene alterations treated with a combination of talazoparib and...
FRIDAY, March 7, 2025 -- Patients with chronic kidney disease (CKD) and heart failure have higher rates of inpatient dialysis initiation than those...
A new study suggests that a combination of radiation therapy and immune checkpoint inhibitors (ICIs) may offer a less invasive alternative to bladder...
Women newly diagnosed with invasive breast cancer (BC) face an increased risk of heart failure if they experience significant weight gain, according...
Carrageenan, a common food additive (E 407) used as a thickener and stabilizer in processed foods, has been linked to gut inflammation, ulcers, and...
Discover how obstructive sleep apnea increases Parkinson's disease risk and how early CPAP therapy can significantly reduce the risk.
TUESDAY, March 4, 2025 -- Breast cancer survivors treated with chemotherapy tend to suffer a longer-lasting decline in their physical health, compared...
MONDAY, March 3, 2025 -- For patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual...